Xylometazoline: Difference between revisions

Jump to navigation Jump to search
No edit summary
(No difference)

Revision as of 20:45, 10 June 2009

Xylometazoline
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H24N2
Molar mass244.38

WikiDoc Resources for Xylometazoline

Articles

Most recent articles on Xylometazoline

Most cited articles on Xylometazoline

Review articles on Xylometazoline

Articles on Xylometazoline in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Xylometazoline

Images of Xylometazoline

Photos of Xylometazoline

Podcasts & MP3s on Xylometazoline

Videos on Xylometazoline

Evidence Based Medicine

Cochrane Collaboration on Xylometazoline

Bandolier on Xylometazoline

TRIP on Xylometazoline

Clinical Trials

Ongoing Trials on Xylometazoline at Clinical Trials.gov

Trial results on Xylometazoline

Clinical Trials on Xylometazoline at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Xylometazoline

NICE Guidance on Xylometazoline

NHS PRODIGY Guidance

FDA on Xylometazoline

CDC on Xylometazoline

Books

Books on Xylometazoline

News

Xylometazoline in the news

Be alerted to news on Xylometazoline

News trends on Xylometazoline

Commentary

Blogs on Xylometazoline

Definitions

Definitions of Xylometazoline

Patient Resources / Community

Patient resources on Xylometazoline

Discussion groups on Xylometazoline

Patient Handouts on Xylometazoline

Directions to Hospitals Treating Xylometazoline

Risk calculators and risk factors for Xylometazoline

Healthcare Provider Resources

Symptoms of Xylometazoline

Causes & Risk Factors for Xylometazoline

Diagnostic studies for Xylometazoline

Treatment of Xylometazoline

Continuing Medical Education (CME)

CME Programs on Xylometazoline

International

Xylometazoline en Espanol

Xylometazoline en Francais

Business

Xylometazoline in the Marketplace

Patents on Xylometazoline

Experimental / Informatics

List of terms related to Xylometazoline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Xylometazoline (Neo-Rinoleina®; Novorin®; Olynth®; Otriven®; Otrivin®; Otrivine®; Xymelin®) is a topical decongestant that is directly dosed into the nose, either as a spray or as drops.

Xylometazoline is marketed under the brand names Otrivine or Otrivin, with the standard adult dose being 0.1% w/v xylometazoline. The dose for children under 12 is 0.05%.

The drug works by constricting the blood vessels in the nose. The vasoconstriction means that there is less pressure in the capillaries and less water can filter out, thus less discharge is made. (If the colour of the nasal passage is observed, it is visibly paler after dosage.)

Xylometazoline is designed to mimic the molecular shape of adrenaline meaning that it binds to the same cell receptors adrenaline does. For this reason, it should not be used by people with high blood pressure, or other heart problems. (It acts mainly on alpha-adrenergic receptors.)

Unfortunately the vessels become resistant to the drug after prolonged dosing. The number of receptors decreases, and when the administration of the drug is ceased, chronic congestion can occur; this is called rhinitis medicamentosa, commonly referred to as rebound congestion. Moreover long-term overdosing can cause degenerative changes in nasal mucous membranes that pose another health problem.


Template:SIB bg:Ксилометазолин de:Xylometazolin hu:Xylometazolin nl:Xylometazoline fi:Ksylometatsoliini


Template:WikiDoc Sources